{"nct_id":"NCT00150462","title":"Safety Study of the Proteasome Inhibitor PR-171 (Carfilzomib for Injection) in Patients With Hematological Malignancies","status":"COMPLETED","status_verified_date":"2017-04","start_date":"2005-09","start_date_type":null,"primary_completion_date":"2009-10","primary_completion_date_type":"ACTUAL","completion_date":"2009-10","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["AMGN"]}